摘要
以前的研究调查轻度认知障碍(MCI)主要集中在认知、记忆、注意力和执行功能减退。目前已有的对知觉减退可能会出现MCI的研究相对较少。这是令人惊讶的,因为已知感觉和认知功能共享一个共同的皮质框架[1]。在下面的研究中,我们通过声致闪光错觉(SIFI)引起一组参与者轻度认知障碍(MCI)和健康对照(HC)进行测试。SIFI是一个视听幻觉,由两蜂鸣器和一个闪光组成。参与者倾向于感知到2次闪烁当蜂鸣的哔哔时间间隔很短时[2,3]。有MCI的参与者更显著错觉,相比HC在较长的蜂鸣时间间隔下。这表明,与HC相比,MCI患者收集到更多的(可以说是无关紧要的)视听资料。通过将感知任务转化为一个临床诊断有可能获得对疾病更全面的了解,以及提供更准确的诊断哪些人可能患有语言障碍。
关键词: 轻度认知损伤,多传感器集成,声音诱导闪光错觉。
Current Alzheimer Research
Title:Expanded Temporal Binding Windows in People with Mild Cognitive Impairment
Volume: 12 Issue: 1
Author(s): Jason S. Chan, Jochen Kaiser, Mareike Brandl, Silke Matura, David Prvulovic, Michael J. Hogan and Marcus J. Naumer
Affiliation:
关键词: 轻度认知损伤,多传感器集成,声音诱导闪光错觉。
摘要: Previous studies investigating mild cognitive impairment (MCI) have focused primarily on cognitive, memory, attention, and executive function deficits. There has been relatively little research on the perceptual deficits people with MCI may exhibit. This is surprising given that it has been suggested that sensory and cognitive functions share a common cortical framework [1]. In the following study, we presented the sound-induced flash illusion (SiFi) to a group of participants with mild cognitive impairment (MCI) and healthy controls (HC). The SiFi is an audio-visual illusion whereby two-beeps and one-flash are presented. Participants tend to perceive two flashes when the time-interval between the auditory beeps is small [2, 3]. Participants with MCI perceived significantly more illusions compared to HC over longer auditory time-intervals. This suggests that MCIs integrate more (arguably irrelevant) audiovisual information compared to HCs. By incorporating perceptual tasks into a clinical diagnosis it may be possible to gain a more comprehensive understanding into the disease, as well as provide a more accurate diagnose to those who may have a language impairment.
Export Options
About this article
Cite this article as:
Jason S. Chan, Jochen Kaiser, Mareike Brandl, Silke Matura, David Prvulovic, Michael J. Hogan and Marcus J. Naumer , Expanded Temporal Binding Windows in People with Mild Cognitive Impairment, Current Alzheimer Research 2015; 12 (1) . https://dx.doi.org/10.2174/1567205012666141218124744
DOI https://dx.doi.org/10.2174/1567205012666141218124744 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vasoactive Intestinal Peptide in Neurodevelopmental Disorders:Therapeutic Potential
Current Pharmaceutical Design Lactoferrin Suppresses Decreased Locomotor Activities by Improving Dopamine and Serotonin Release in the Amygdala of Ovariectomized Rats
Current Molecular Pharmacology Recent Software Developments and Applications in Functional Imaging
Current Pharmaceutical Biotechnology Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy
Current Alzheimer Research The Bioanalytical Molecular Pharmacology of the N-methyl-<sub>D</sub>-Aspartate (NMDA) Receptor Nexus and the Oxygen-Responsive Transcription Factor HIF-1α : Putative Mechanisms and Regulatory Pathways Unravel the Intimate Hypoxia Connection
Current Molecular Pharmacology Development of Radiotracers for the Determination of the Beta-Cell Mass In Vivo
Current Pharmaceutical Design Recently Patented Applications of Homologous Cellular and Extracellular Agents as Therapeutics or Targets for the Prevention of Restenosis Post- Angioplasty
Recent Patents on Cardiovascular Drug Discovery Delayed Neuroleptic Malignant Syndrome Associated with the Use of Low Dose Risperidone in Conjunction with Cholinergic Drugs-the Dangers of Polypharmacy in the Elderly
Current Drug Therapy Quantitative Ultrasound in Diagnosis of Metabolic Bone Diseases
Current Medical Imaging Effects of Early Maternal Separation on Biobehavioral and Neuropathological Markers of Alzheimer's Disease in Adult Male Rats
Current Alzheimer Research Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease
Current Topics in Medicinal Chemistry Physicochemical Strategies for Inhibition of Amyloid Fibril Formation: An Overview of Recent Advances
Current Medicinal Chemistry Extracellular Vesicles as Drug Delivery Vehicles for Rheumatoid Arthritis
Current Stem Cell Research & Therapy Usefulness of 18F Florbetaben in Diagnosis of Alzheimer’s Disease and Other Types of Dementia
Current Alzheimer Research Zederone Improves the Fecal Microbial Profile in Dementia Induced Rat Model: A First Report
CNS & Neurological Disorders - Drug Targets Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
Current Medicinal Chemistry Mechanisms for Antiplatelet Action of Statins
Current Drug Targets - Cardiovascular & Hematological Disorders Mitochondria: A Target for Neuroprotective Interventions in Cerebral Ischemia-Reperfusion
Current Pharmaceutical Design Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway
Central Nervous System Agents in Medicinal Chemistry Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued)